Cargando…
Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma
Immunotherapy drugs are gaining popularity in the treatment of certain malignancies due to the success of these agents in recent clinical trials. Pembrolizumab is an immune checkpoint inhibitor that acts via binding to programmed cell death 1 (PD-1) receptors on T-cells, allowing for the constitutiv...
Autores principales: | Kichloo, Asim, Albosta, Michael S., McMahon, Shane, Movsesian, Kimberly, Wani, Farah, Jamal, Shakeel M., Aljadah, Michael, Singh, Jagmeet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448133/ https://www.ncbi.nlm.nih.gov/pubmed/32830561 http://dx.doi.org/10.1177/2324709620951339 |
Ejemplares similares
-
Atezolizumab-Induced Bell’s Palsy in a Patient With Small Cell Lung
Cancer
por: Kichloo, Asim, et al.
Publicado: (2020) -
COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma
por: Kichloo, Asim, et al.
Publicado: (2020) -
Emerging therapeutics in the management of COVID-19
por: Kichloo, Asim, et al.
Publicado: (2021) -
COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020) -
Hyperkalemia: Major but still understudied complication among heart transplant recipients
por: Singh, Jagmeet, et al.
Publicado: (2021)